Legend Biotech Corporation (LEGN) Financials
LEGN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.8 billion | 589.9 million |
2023-09-30 | 1.8 billion | 499.7 million |
2023-06-30 | 1.9 billion | 523.6 million |
2023-03-31 | 1.2 billion | 556.2 million |
LEGN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -118.7 million | 12.6 million |
2023-09-30 | -66.3 million | 12.4 million |
2023-06-30 | -106.1 million | ? |
2023-03-31 | -141.1 million | ? |
LEGN Net Income
No data available :(
LEGN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 1.3 billion | - | 47.3 million |
2023-09-30 | 1.4 billion | - | 44.6 million |
2023-06-30 | 1.5 billion | - | 48.0 million |
2023-03-31 | 850.1 million | - | 48.9 million |
LEGN Shares Outstanding
LEGN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 25.4 million | 105.7 million | 62.4 million | - |
2023-09-30 | 5.5 million | 95.9 million | 28.1 million | 21.1 million |
2023-06-30 | 10.4 million | 95.8 million | 27.8 million | 21.4 million |
2023-03-31 | 10.4 million | 84.9 million | 22.2 million | 18.0 million |
LEGN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 79.5 million | 37.8 million |
2023-09-30 | 96.0 million | 43.5 million |
2023-06-30 | 73.3 million | 32.7 million |
2023-03-31 | 36.3 million | 35.6 million |
LEGN
Price: $45.99
52 week price:
Earnings Per Share: -2.94 USD
P/E Ratio: -20.60
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 302700
Market Capitalization: 9.6 billion